drugset

drugset / Trial / NCT06170983

Skin Inflammation and PK of Azithromycin

NCT06170983 ↗

Unknown 36 enrolled Medical University of Vienna

Non-randomizedSequentialOpen-labelBasic science

Summary

This study will investigate the tissue distribution of azithromycin in healthy, artificially inflamed and actually infected tissue of humans.

Timeline

Start: 2024-01-01
Primary completion: 2026-01-01
Completion: 2026-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azithromycin	Small molecule	500 mg	—

Indications